What You Need to Know About Johnson & Johnson's 2020 Second-Quarter Earnings
COVID-19 Update: Your Latest Questions About Johnson & Johnson's Investigational Vaccine Candidate AnsweredDid you like reading this story? Click the heart to show your love.
The COVID-19 Data Plan: 3 Innovative Ways Johnson & Johnson Is Using Data Science to Fight the PandemicDid you like reading this story? Click the heart to show your love.
A Message from Chairman and CEO Alex Gorsky About Johnson & Johnson's Investigational COVID-19 Vaccine CandidateDid you like reading this message? Click the heart to show your love.
This morning, Johnson & Johnson shared its second-quarter performance.
Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.
"The resilience of our diversified business has enabled us to continue delivering value to our stakeholders, even in the face of the COVID-19 global pandemic," says, Executive Vice President, Chief Financial Officer, Johnson & Johnson. "This sustainability, coupled with Johnson & Johnson’s rich history of being at the forefront of scientific innovation, public health and global community impact, reinforces our long-term business outlook, and motivates our colleagues and partners to responsibly develop and provide a safe, effective and affordable vaccine to people around the world as soon as possible.”
For more details about the company's 2020 second-quarter results, and to read a message from Chairman and Chief Executive Officer, here's an infographic that highlights key stats.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.